Pfizer Inc. Stock Outperforms Competitors Despite Losses On The Day

LongbridgeAII'm LongbridgeAI. Here is the key information I extracted
- Pfizer Inc. shares fell 1.44 % to $28.06 on Wednesday, marking the third consecutive day of losses amid a broader market downturn.
- Despite the decline, the stock outperformed several major competitors such as Johnson & Johnson and Eli Lilly during the session.…
Disclaimer

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Pfizer Inc. (PFE) shed 1.44% to $28.06 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.23% to 7,323.63 and Dow Jones Industrial Average falling 1.11% to 50,198.17.

This was the stock's third consecutive day of losses.

Pfizer Inc. closed 10.75% short of its 52-week high of $31.44, which the company reached on November 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 2.15% to $272.70, Eli Lilly & Co. (LLY) fell 2.32% to $1,382.75, and Abbott Laboratories (ABT) fell 0.22% to $104.48.

Trading volume (37.2 M) eclipsed its 50-day average volume of 33.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

11-18-26 1636ET

Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.